<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The description of a <z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome in patients with systemic <z:e sem="disease" ids="C0866588" disease_type="Disease or Syndrome" abbrv="">lupus erythematodes</z:e> (SLE) filled up a gap in defining an "atypical" subgroup--quite often negative to DNA antibodies but suffering from arterial thromboses, <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo>, aseptic bone necroses, and <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>54 patients with SLE and 32 of their closet blood relatives were examined for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> anticoagulation factor, anticardiolipin antibodies and Wassermann test </plain></SENT>
<SENT sid="2" pm="."><plain>The results were interpreted in relation to the forms of the disease and its clinical manifestations </plain></SENT>
<SENT sid="3" pm="."><plain>Clinically healthy relatives positive for circulating <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> anticoagulation factor or <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> are under close control </plain></SENT>
</text></document>